October 22, 2025

FDA Redefining Depression Treatment with New Approvals?

Researchers analyze FDA-approved and Phase 3 antidepressants from 2009 to 2025.

Conexiant

October 22, 2025

Primary Care Workload: 62 Hours Weekly

Electronic records detail physician work hours across multiple primary care clinics.

Conexiant

October 22, 2025

Early ED Indicators Predict 30-Day mTBI Symptoms

One-third of patients say headache remains the most common symptom after mild traumatic brain injury.

Conexiant

October 21, 2025

After the Light: Searching for Support

Most near-death experiencers sought help to process their episode, and validation made a difference—those met with understanding rated support as more effective; deeper experiences drove help-seeking, while stigma and access issues often stood in the way.

Conexiant

October 21, 2025

What’s Driving Med School Picks?

More US medical students now consider campus diversity vital in choosing where to enroll.

Conexiant

October 20, 2025

Which Hair Loss Treatments Truly Deliver Results?

Researchers compare prescription and over-the-counter treatments for male hair loss to determine which best improve hair density.

Conexiant

October 17, 2025

FDA Awards Nine CNPV Vouchers to Speed Reviews

Pilot aims to expedite access to high‑impact therapies by streamlining FDA review and strengthening sponsor–agency collaboration.

Conexiant

October 16, 2025

‘Dying Alone’: The Growing Challenge for Seniors

An increasing number of older adults are living and dying alone, highlighting the need for physicians to address end-of-life care for patients without family or caregivers.

KFF Health News

October 16, 2025

HHS Memo: Fringe Finds a Footing

From wheat fields to Washington: a decades-old fear about skies and 'sprays' rises again, colliding with science, social media, and the machinery of federal policymaking.

KFF Health News